Patent application number | Description | Published |
20110157945 | Synchronous Rectifier Circuit - A synchronous rectifier circuit rectifies an AC input voltage to produce a DC output voltage. The synchronous rectifier circuit comprises MOSFET switches coupled within the secondary transformer windings resulting in a shortened AC current path compared to conventional synchronous rectifier circuits. The shortened current path mitigates skin and proximity effects, substantially improving the power efficiency of the synchronous rectifier circuit. A rectifier assembly integrates one or more synchronous rectifier circuit within a magnetic core. | 06-30-2011 |
20120176827 | CONTROLLER FOR SECONDARY SIDE CONTROL OF A SWITCH, POWER CONVERTER, AND RELATED SYNCHRONOUS RECTIFICATION CONTROL METHOD - A controller, power converter, and a related method for secondary side control of a switch are disclosed herein. An embodiment of the present invention includes a controller. The controller comprises a drain to source voltage (V | 07-12-2012 |
20150222173 | POWER CONVERTER WITH FAST DISCHARGE CIRCUIT - A power converter with fast discharging to adapt to a load disconnect. The power converter comprises a magnetic component coupled between an input of the power converter and an output of the power converter. The magnetic component includes a primary winding and a secondary winding. A switch controls transfer of energy from the primary winding to the secondary winding according to on and off times of the switch. A discharge circuit is coupled to the output of the power converter. The discharge circuit is adapted to receive a signal indicative of whether the load is disconnected and to decrease an output voltage at the output of the power converter based on the signal indicative of whether the load is disconnected. | 08-06-2015 |
20160141975 | Capacitor Drop Power Supply - A capacitor drop power supply is provided where excess charge is damped into a low impedance switch, avoiding the dissipation of extra energy seen in current designs. Also, because the excess charge is not dissipated, it then becomes available for when a load is applied thus increasing the efficiency of the power supply. The present disclosure therefore provides various advantages compared with existing capacitor drop power supplies. It provides the simplicity and low cost of a capacitor drop power supply, but with an efficiency that is equivalent or superior to that of a switching mode power supply. | 05-19-2016 |
Patent application number | Description | Published |
20080263482 | Method and Apparatus for Small Die Low Power System-on-Chip Design with Intelligent Power Supply Chip - A method and system of system-on-chip design that provides the benefits of reduced design time, a smaller die size, lower power consumption, and reduced costs in chip design and production. The process seeks to remove the worst performance and worst power case scenarios from the design and application phases. This is accomplished by planning the power supply voltage in the design phase along with its tolerance with process corner and temperature combinations. The established plan is then applied with communications between power supply integrated circuits and load system-on-chip. | 10-23-2008 |
20100207655 | Method and Apparatus for Small Die Low Power System-on-chip Design with Intelligent Power Supply Chip - A method and system of system-on-chip design that provides the benefits of reduced design time, a smaller die size, lower power consumption, and reduced costs in chip design and production. The process seeks to remove the worst performance and worst power case scenarios from the design and application phases. This is accomplished by planning the power supply voltage in the design phase along with its tolerance with process corner and temperature combinations. The established plan is then applied with communications between power supply integrated circuits and load system-on-chip. | 08-19-2010 |
20150076999 | Modifying Duty Cycles of PWM Drive Signals to Compensate for LED Driver Mismatches in a Multi-Channel LED System - An LED (Light Emitting Diode) controller comprises a first LED driver to generate a first PWM (Pulse Width Modulation) drive signal to turn on or turn off, respectively, a first current through a first LED string. Additionally, the LED controller comprises a compensation circuit to generate the first PWM drive signal responsive to a first duty set signals. The first duty set signal is indicative of a first duty cycle set for the first PWM drive signal. The compensation circuit receives a first feedback signal indicative of the first current, generates a first error signal indicative of a difference between a first predetermined target value and the first feedback signal, and generates the first PWM drive signal to have the first duty cycle corresponding to the first duty set signal and further adjusted by the first error signal. | 03-19-2015 |
20150124494 | ADAPTIVE SYNCHRONOUS RECTIFIER CONTROL - The embodiments herein describe a switched mode power converter. In particular, the embodiments herein disclose techniques for adaptive synchronous rectification control. The switched mode power supply includes a synchronous rectifier controller that determines when to turn off the synchronous rectifier during each switching cycle based on a reference signal corresponding to when substantially all the power stored in a transformer of the power supply has been delivered to an electronic load. The synchronous rectifier controller may determine whether to adjust the reference signal used by the synchronous rectifier controller to turn off the synchronous rectifier during subsequent switching cycles. | 05-07-2015 |
20150188442 | CURRENT METER FOR LOAD MODULATION COMMUNICATION RECEIVER ARCHITECTURE - A load device on a secondary side of an isolated switching power converter communicates a digital message to a primary side controller by modulating the load current in accordance with certain predefined timing patterns. The load current modulation is detected by the primary side controller and the digital message is decoded based on the predefined timing patterns. The load device may encode the digital message in order to control the primary side controller to operate in a particular mode compatible with the load device. | 07-02-2015 |
Patent application number | Description | Published |
20080279825 | CARTILAGE MATERIAL - Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect. | 11-13-2008 |
20090018659 | INVERTEBRAL SPINAL IMPLANT AND METHOD OF MAKING THE SAME - An invertebral implant for replacing a damage invertebral disk within the spinal column can include a generally flat body having opposing surfaces. To promote bone growth and fusion of the adjacent vertebrae together, in an aspect, the implant can be provided with osteogenic or medicinal material received into one or more apertures disposed into the surfaces of the implant. To better retain the osteogenic material, the apertures can be disposed on a non-perpendicular angle with respect to the implant and/or can be tapered. In another aspect, the implant can include a plurality of grooves disposed across a surface to reduce slipping of the inserted implant between the adjacent vertebrae. In a further aspect, the implant can be formed by cutting a plurality of implants parallel along the diaphysis of a long bone. In another aspect, the implant can be generally as a bow or question mark. | 01-15-2009 |
20100268339 | Intervertebral Spinal Implant and Method of Making the Same - An invertebral implant for replacing a damage invertebral disk within the spinal column can include a generally flat body having opposing surfaces and peripheral wall or surface that extends between the opposing surface. Protruding outwardly from the peripheral wall can be a shelf-like flange that has a reduced thickness compared to the thickness of the main body of the implant. The flange provides an object or structure that the surgeon can grasp with forceps during insertion between adjacent vertebrae. Because the protruding nature and reduced thickness of the flange, both the flange and the forceps placed thereon can fit within or adjacent to the intervertebral space between the adjacent vertebrae without interfering with orientation or placement of the main body between the vertebrae. Hence, the flange may simplify the surgical insertion procedure. | 10-21-2010 |
20110009967 | Intervertebral Spinal Implant and Method of Making the Same - An intervertebral implant for replacing a damage intervertebral disk within the spinal column can include a generally flat body having opposing surfaces. To promote bone growth and fusion of the adjacent vertebrae together, in an aspect, the implant can be provided with osteogenic or medicinal material received into one or more apertures disposed into the surfaces of the implant. To better retain the osteogenic material, the apertures can be disposed on a non-perpendicular angle with respect to the implant and/or can be tapered. In another aspect, the implant can include a plurality of grooves disposed across a surface to reduce slipping of the inserted implant between the adjacent vertebrae. In a further aspect, the implant can be formed by cutting a plurality of implants parallel along the diaphysis of a long bone. In another aspect, the implant can be generally as a bow or question mark. | 01-13-2011 |
20110052705 | CARTILAGE COMPOSITION AND PROCESS FOR PRODUCING THE CARTILAGE COMPOSITION - Disclosed is a method for regenerating articular cartilage in an animal comprising administering a therapeutically effective amount of a non-demineralized particulate articular cartilage having a distribution of particle sizes within the range of from about 60 microns to about 500 microns. | 03-03-2011 |
20110104242 | CARTILAGE MATERIAL - Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect. | 05-05-2011 |
20120283829 | FAN FOLDED FASCIA LATA FOR CRUCIATE LIGAMENT SUBSTITUTION AND METHOD AND APPARATUS FOR MAKING THE SAME - Cruciate ligament substitutes are formed using fan-folded fascia lata grafts. Devices of making the same and methods of making and using the same are described herein. The fan-folded fascia lata cruciate ligament substitutes disclosed herein are used in a single-loop fashion and have surprisingly exhibited load to failure and stiffness values that compare favorably with conventional grafts, including tibialis anterior, tibialis posterior, peroneus longus, and bone-patellar tendon-bone (BPTB) half-patella specimens. It has been demonstrated that single-loop, fan-folded fascia lata sheets can exhibit mechanical properties that compare favorably with existing cruciate ligament grafts. An apparatus for handling a fascia lata sheet can include a first and a second removable anchoring member. A method of producing a cruciate ligament substitute can include providing a fascia lata sheet secured in a fan-folded orientation with at least one removable anchoring member, and securing the fan-folded fascia lata in a fan-folded orientation with at least one permanent anchoring member. | 11-08-2012 |
20130330391 | CARTILAGE MATERIAL - Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect. | 12-12-2013 |
20140220096 | CARTILAGE MATERIAL - Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect. | 08-07-2014 |
20140294911 | CARTILAGE MATERIAL - Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect. | 10-02-2014 |
20150037432 | SELF-ASSEMBLY OF COLLAGEN FIBERS FROM DERMIS, FASCIA AND TENDON FOR TISSUE AUGMENTATION AND COVERAGE OF WOUNDS AND BURNS - The present invention is a composition of a self-assembly of collagen fibers made from a plurality of sized pieces of a source material. The source material made from animal or human tissue selected from one of dermis, tendon, fascia or dura mater. The self-assembly occurring by induction of a magnetic field in a liquid medium. | 02-05-2015 |
20150140096 | COMPOSITION AND METHOD OF PREPARATION OF BONE ALLOGRAFT FROM ENDOSTEAL PORTION OF BONE AND ISOLATED BONE PERIOSTEUM - Particulate bone and structural bone, more specifically decalcified bone from endosteum having osteoinductive capacity and methods for their isolation and production are provided, more specifically, decalcified bone preparations derived from endosteal layer of bone are provided. Compositions formulated with material from endosteal layer of bone are provided along with preparation and methods of using decalcified endosteal compositions are disclosed. Endosteum is avascular and areolar in distinction to bone marrow which fills the canal. Because of its structure and anatomic position, endosteum is difficult to isolate and recognize, and therefore not regarded as an important constituent of allograft materials. One embodiment of the present invention allows for recognition and isolation of endosteum. | 05-21-2015 |
20150258243 | COMPOSITION AND METHOD OF PREPARATION OF BONE ALLOGRAFT FROM ENDOSTEAL PORTION OF BONE AND ISOLATED BONE PERIOSTEUM - Particulate bone and structural bone, more specifically decalcified bone from endosteum having osteoinductive capacity and methods for their isolation and production are provided, more specifically, decalcified bone preparations derived from endosteal layer of bone are provided. Compositions formulated with material from endosteal layer of bone are provided along with preparation and methods of using decalcified endosteal compositions are disclosed. Endosteum is avascular and areolar in distinction to bone marrow which fills the canal. Because of its structure and anatomic position, endosteum is difficult to isolate and recognize, and therefore not regarded as an important constituent of allograft materials. One embodiment of the present invention allows for recognition and isolation of endosteum. | 09-17-2015 |
20150344847 | Method For Production Of Large Numbers Of Cartilage Cells With Phenotype Retention - A method for production of large numbers of cartilage cells with phenotype retention intended for treatment of articular cartilage lesions or preparing viable cartilage tissue by propagation of chondrocytes from cartilage explants, human or animal, with the retention of phenotypes of the cartilage cells, in which cells are chondrocytes retaining morphologic attributes of the same or chondrocyte progenitor cells. The method includes culturing the cells in which cultured cells are organized into mature hyaline cartilage on the surface of biologic structures such as cancellous or cortical bone lamina. The method for culturing chondrocytes to produce three dimensional cellular structures consisting of cartilage cells and cell produced extracellular cartilage matrix. | 12-03-2015 |
20150352235 | TISSUE ALLOGRAFT STERILIZATION METHOD - The invention is a novel method of sterilizing bone and soft tissues intended for human transplantation. In one embodiment the process includes steps of subjecting transplants to high hydrostatic pressures of aqueous fluid to which chlorhexidine gluconate or similar sterilizing chemicals have been added. | 12-10-2015 |
20160051298 | BONE PLATE AND METHOD OF USE - A bone plate assembly has the screws on one plate, either distal or proximal to the fracture, placed through round holes perpendicular to long axis of a first bone thus securing the plate rigidly to the bone on one side relative to the fracture. The screw holes can be either threaded on non-threaded. On the other side of the fracture, the bone fragment is first secured with an inclined screw placed from less than 90 to 10 degrees towards the fracture. As the screw is tightened it advances away from the fracture pulling the first bone, securely attached, plate towards the fracture site and thus compressing the fracture. | 02-25-2016 |
Patent application number | Description | Published |
20090130193 | Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intraperitoneally - One aspect of the invention relates to methods of treating cancer in a patient comprising administering intraperitoneally to a patient in need thereof a cancer treating effective amount of a composition comprising a lipid-complexed platinum compound wherein the concentration of the platinum compound of the lipid-complexed platinum compound composition is greater than about 1.2 mg/ml. Another aspect of the invention relates to lipid-complexed platinum compound compositions where the concentration of the platinum compound is greater than about 1.2 mg/ml. | 05-21-2009 |
20090130194 | Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intravenously - In one aspect, the present invention relates to methods of treating cancer in a patient comprising administering intravenously to a patient in need thereof a cancer treating effective amount of a lipid-complexed platinum compound composition wherein the concentration of the platinum compound of the lipid-complexed platinum compound composition is greater than about 1.2 mg/ml. | 05-21-2009 |
20100196455 | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof - The present invention relates, in part, to a composition comprising a multicationic drug and an organic multianion. In some embodiments, the multicationic drug is enclosed within a carrier. In some embodiments, the carrier is a liposome. In some embodiments, the multicationic drug and organic multianion are enclosed within a carrier, while in other embodiments, the multicationic drug is enclosed within the carrier and the organic multianion is outside the carrier. The present invention also relates, in part, to a method of treating a subject for pulmonary distress comprising administering to a subject in need thereof the aforementioned composition. | 08-05-2010 |
20100260829 | Sustained Release of Antiinfectives - Provided are lipid antiinfective formulations substantially free of anionic lipids with a lipid to antiinfective ratio is about 1:1 to about 4:1, and a mean average diameter of less than about 1 μm. Also provided is a method of preparing a lipid antiinfective formulation comprising an infusion process. Also provided are lipid antiinfective formulations wherein the lipid to drug ratio is about 1:1 or less, about 0.75:1 or less, or about 0.50:1 or less prepared by an in line fusion process. The present invention also relates to a method of treating a patient with a pulmonary infection comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. The present invention also relates to a method of treating a patient for cystic fibrosis comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. | 10-14-2010 |
20110159079 | High Delivery Rates for Lipid Based Drug Formulations, and Methods of Treatment Thereof - Provided is a method of preparing lipid based drug formulations with low lipid/drug ratios using coacervation techniques. Also provided are methods of delivering such lipid based drug formulations at high delivery rates, and methods of treating patients with pulmonary diseases comprising administering such lipid based drug formulations. | 06-30-2011 |
20130330400 | SYSTEMS FOR TREATING PULMONARY INFECTIONS - Provided herein are systems for treating a subject with a pulmonary infection, for example, a nontuberculous mycobacterial pulmonary infection, a | 12-12-2013 |
20140248335 | COMPOSITIONS OF MULTICATIONIC DRUGS FOR REDUCING INTERACTIONS WITH POLYANIONIC BIOMOLECULES AND METHODS OF USE THEREOF - The present invention relates, in part, to a composition comprising a multicationic drug and an organic multianion. In some embodiments, the multicationic drug is enclosed within a carrier. In some embodiments, the carrier is a liposome. In some embodiments, the multicationic drug and organic multianion are enclosed within a carrier, while in other embodiments, the multicationic drug is enclosed within the carrier and the organic multianion is outside the carrier. The present invention also relates, in part, to a method of treating a subject for pulmonary distress comprising administering to a subject in need thereof the aforementioned composition. | 09-04-2014 |
20140314835 | SUSTAINED RELEASE OF ANTIINFECTIVES - Provided are lipid antiinfective formulations substantially free of anionic lipids with a lipid to antiinfective ratio is about 1:1 to about 4:1, and a mean average diameter of less than about 1 μm. Also provided is a method of preparing a lipid antiinfective formulation comprising an infusion process. Also provided are lipid antiinfective formulations wherein the lipid to drug ratio is about 1:1 or less, about 0.75:1 or less, or about 0.50:1 or less prepared by an in line fusion process. The present invention also relates to a method of treating a patient with a pulmonary infection comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. The present invention also relates to a method of treating a patient for cystic fibrosis comprising administering to the patient a therapeutically effective amount of a lipid antiinfective formulation of the present invention. | 10-23-2014 |
20150148414 | PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF - Prostacyclin compounds and compositions comprising the same are provided herein. Specifically, prostacyclin compounds comprising treprostinil covalently linked to a linear C | 05-28-2015 |
20150175529 | PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF - Prostacyclin compounds and compositions comprising the same are provided herein. Specifically, prostacyclin compounds comprising treprostinil covalently linked to a linear C | 06-25-2015 |
20150272880 | SYSTEMS FOR TREATING PULMONARY INFECTIONS - Provided herein are systems for treating a subject with a pulmonary infection, for example, a nontuberculous mycobacterial pulmonary infection, a | 10-01-2015 |
20150314002 | STABILIZED VANCOMYCIN FORMULATIONS - In one aspect, the invention provides a stabilized lipid-based glycopeptide antibiotic composition and a process for producing the same. In another aspect, the invention provides methods for treating a bacterial pulmonary infection by administering to a subject in need thereof a therapeutically effective amount of the stabilized lipid-based glycopeptide antibiotic composition. | 11-05-2015 |
20150328232 | PROSTACYLIN COMPOSITIONS AND METHODS FOR USING THE SAME - The present invention relates to pharmaceutical compositions comprising a prostacyclin, a cationic compound, and a surfactant. Particulate compositions, including liposomal, solid nanoparticulate prostacyclin compositions, including treprostinil formulations comprising cationic compound and the surfactant are also described. The present invention also relates to a system comprising the pharmaceutical composition and an inhalation device. Methods for treating pulmonary hypertension and portopulmonary hypertension with the compositions and systems described herein are also provided. | 11-19-2015 |
Patent application number | Description | Published |
20090177111 | System and method for displaying contact between a catheter and tissue - A system and method for assessing and displaying a degree of contact between a sensor, an electrode, and tissue in a body is provided. Values for the sensor are read, and a degree of contact is calculated. This degree of contact is displayed to a clinician in a variety of ways to indicate the degree of contact to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely. | 07-09-2009 |
20100168735 | SYSTEM AND METHOD FOR ASSESSING COUPLING BETWEEN AN ELECTRODE AND TISSUE - A system and method for assessing a degree of coupling between an electrode and tissue in a body is provided. Values for first and second components of a complex impedance (e.g., resistance and reactance or impedance magnitude and phase angle) between the electrode and the tissue are obtained. These values are used together with a standardization value indicative of a deviation from a reference standard by a parameter associated with at least one of the body, the electrode and another component of the system to calculate a coupling index that is indicative of a degree of coupling between the electrode and the tissue. The coupling index may be displayed to a clinician in a variety of ways to indicate the degree of coupling to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely. | 07-01-2010 |
20110144785 | SYSTEM AND METHOD FOR GENERATING INSTRUCTIONS FOR CUSTOMIZATION - A method of creating a triangulated surfaces for generating machine readable instructions for customization is provided. The method comprises selecting text or symbols. The text or symbols are spaced. The text or symbols are mapped between first and second curves. Triangulated surfaces are generated from the mapped text or symbols. The triangulated surfaces are converted to machine readable instructions. | 06-16-2011 |
20120075297 | SYSTEM AND METHOD FOR SMOOTHING THREE DIMENSIONAL IMAGES - A method and system for converting two-dimensional artwork into three-dimensional models. Data relating to an image is imported and segments of the image are chained into contiguous curves. The contiguous curves together may form loops. Subsets of closed loops are split and created where surfaces of the image are to be created. The closed loops are contoured to create contours. The geometries created are projected onto a surface as an image. Finally, the image is smoothed. | 03-29-2012 |
20130274907 | SYSTEM AND METHOD FOR GENERATING INSTRUCTIONS FOR CUSTOMIZATION - A method of creating a triangulated surfaces for generating machine readable instructions for customization is provided. The method comprises selecting text or symbols. The text or symbols are spaced. The text or symbols are mapped between first and second curves. Triangulated surfaces are generated from the mapped text or symbols. The triangulated surfaces are converted to machine readable instructions. | 10-17-2013 |
20130333181 | SYSTEM AND METHOD FOR EMBELLISHMENT PLACEMENT - A method for embellishment placement is provided. More specifically, an automated method for determining placement of embellishments for an item, such as a jewelry item, is provided. In one embodiment, the method comprises, determining and setting values for parameters, creating offsets along a portion of the item to be embellished, setting points along the offsets, randomizing the points, adding decorative features to the item, and eliminating points based on the parameter values, After points violating the parameter values have been eliminated, the remaining points comprise positions for embellishments. | 12-19-2013 |
20140107430 | System and method for assessing coupling between an electrode and tissue - A system and method for assessing a degree of coupling between an electrode and tissue in a body is provided. Values for first and second components of a complex impedance (e.g., resistance and reactance or impedance magnitude and phase angle) between the electrode and the tissue are obtained. These values are used together with a standardization value indicative of a deviation from a reference standard by a parameter associated with at least one of the body, the electrode and another component of the system to calculate a coupling index that is indicative of a degree of coupling between the electrode and the tissue. The coupling index may be displayed to a clinician in a variety of ways to indicate the degree of coupling to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely. | 04-17-2014 |
20160095642 | System and method for assessing coupling between an electrode and tissue - A system and method for assessing a degree of coupling between an electrode and tissue in a body is provided. Values for first and second components of a complex impedance (e.g., resistance and reactance or impedance magnitude and phase angle) between the electrode and the tissue are obtained. These values are used together with a standardization value indicative of a deviation from a reference standard by a parameter associated with at least one of the body, the electrode and another component of the system to calculate a coupling index that is indicative of a degree of coupling between the electrode and the tissue. The coupling index may be displayed to a clinician in a variety of ways to indicate the degree of coupling to the clinician. The system and method find particular application in ablation of tissue by permitting a clinician to create lesions in the tissue more effectively and safely. | 04-07-2016 |